The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
|Articles|September 19, 2011
Lawsuit Says Kashi’s “All Natural” Claims Should Not Apply to Specialty Ingredients Like Plant Sterols
The lawsuit argues that certain ingredients in the products do not merit the claim.
Advertisement
Kashi Co. and its parent company Kellogg Co. are the target of a new class action lawsuit that accuses the brand of stating that its products are “all natural,” arguing that certain ingredients in the products do not merit the claim. “Unnatural substances” in contention include bromelain, plant sterols, potassium bicarbonate, xanthan gum, yeast extract, inulin, cholecalciferol, ascorbic acid, calcium caseinate, lactic acid, high oleic safflower oil, and certain soy products.
The story was reported by FDA Law Blog. Read more
Nutritional Outlook thanks Harry Rice, PhD, for the tip.
Advertisement
Related to this article
AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
The proposed notification requirement is straightforward, but its legal and commercial consequences are not.
The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5